Projects per year
Search results
-
Active
Expanded umbilical cord blood cells for neuroprotection in extremely preterm infants
McDonald, C., Malhotra, A., Yawno, T., Paton, M. C. B., Penny, T., Miller, S., Jenkin, G., Hunt, R., Zhou, L., Fahey, M. & Gregory, G.
Department of Health and Aged Care (Australia)
1/02/23 → 31/01/27
Project: Research
-
A phase 3, multicenter, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to R-CHOP versus R-CHOP in previously untreated, high-intermediate and high-risk patients with newly-diagnosed diffuse large B-cell lymphoma (DLBCL)
9/08/21 → 8/08/26
Project: Research
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Acalabrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects ≤65 Years with Previously Untreated Non-Germinal Center Diffuse Large B-Cell Lymphoma
4/03/21 → 3/03/26
Project: Research
-
A Phase 1/2, Open-Label, Dose-Escalation Trial of GEN3013 in Patients with Relapsed, Progressive or Refractory B-Cell Lymphoma
21/08/20 → 20/08/25
Project: Research
-
Assessing tumour and host biomarkers to understand responses of central nervous system lymphoma to immunotherapy
1/04/20 → 31/03/24
Project: Research
-
-
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab and Chp (R-Chp) Versus Rituximab and Chop (R-Chop) In Previously Untreated Patients with Diffuse Large B-Cell Lymphoma
29/03/19 → 28/03/24
Project: Research
-
An Open-Label, Multicenter, Phase I/Ib Trial Evaluating the Safety and Pharmacokinetics of Escalating Doses of BTCT4465A as a Single Agent and Combined with Atezolizumab in Patients with Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia
3/12/18 → 2/12/23
Project: Research